David Weiner

David Weiner currently serves as an Independent Director at Bright Minds Biosciences and holds multiple positions as Co-Founder at Bend Therapeutics, Chief Medical Officer at SwanBio Therapeutics, and Co-Executive Chair and Independent Director at AxoSim, all established in 2022. Weiner was previously the Chief Medical Officer at Therini Bio, Inc. and Chemomab Therapeutics from 2021 to 2023, and the Chief Executive Officer at Amathus Therapeutics from 2019 to 2021. Additional experience includes serving as Chief Medical Officer at Lumos Pharma from 2016 to 2019, Chief Medical Officer and Interim Chief Executive Officer at Proteostasis Therapeutics, Inc. from 2012 to 2014, and Chief Medical Officer at aTyr Pharma from 2014 to 2015.